drugset / Trial / NCT01416220

Lithium Versus Paroxetine in Major Depression

NCT01416220

Phase 4 Withdrawn Nova Scotia Health Authority
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is being done to look at how well people respond to two different drug treatments for depression. Clinically, people can respond differently to different treatments for reasons which are not always clear. Some research shows that people with a family history of bipolar disorder or completed suicide may react differently to standard medications used to treat depression than those without a family history. The investigators need to know if these drugs are effective to use in patients with depression who have a family history of bipolar disorder or completed suicide.

Timeline

Start
2011-09
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Lithium Unknown 900 mg Oral
Comparator Paroxetine Small molecule 20 mg Oral